Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

19.75
Delayed Data
As of Jun 28
 +0.70 / +3.67%
Today’s Change
13.60
Today|||52-Week Range
33.00
+5.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues127.5M135.6M140.6M119.4M
 
 
 
 
 
Cost of Goods Sold20.6M21.9M24.6M19.7M
 
 
 
 
 
Depreciation And Amortization6.0M5.9M5.8M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income100.9M107.8M110.3M94.0M
 
 
 
 
 
General Expenses105.7M109.2M112.3M97.9M
 
 
 
 
 
Research And Development50.3M54.8M53.8M46.5M
 
 
 
 
 
Total Operating Expenses132.3M137.0M142.7M123.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.8M-1.4M-2.1M-3.9M
 
 
 
 
 
Extraordinary Credit0.000.003.3M--
 
 
Extraordinary Charge-9.2M-4.1M-500.0K-11.4M
 
 
 
 
 
Interest Expense On Debt4.0M4.4M4.4M4.1M
 
 
 
 
 
Other Expenses-1.9M-179.0K1.6M-444.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.9M-10.0M-2.1M-19.8M
 
 
 
 
 
Income Taxes-972.0K-3.0M-1.0M-918.0K
 
 
 
 
 
Minority Interest-678.0K-307.0K0.000.00
 
 
 
Net Income-18.3M-12.7M-3.1M-18.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.3M45.4M45.5M45.8M
 
 
 
 
 
Shares To Calculate EPS Diluted45.3M45.4M45.5M45.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.28-$0.07-$0.41
 
 
 
 
 
EPS Diluted-$0.40-$0.28-$0.07-$0.41